168 related articles for article (PubMed ID: 10050987)
1. Comparison between fractionated high dose rate irradiation and continuous low dose rate irradiation in spheroids.
Omura M; Torigoe S; Kurihara H; Matsubara S; Kubota N
Acta Oncol; 1998; 37(7-8):681-6. PubMed ID: 10050987
[TBL] [Abstract][Full Text] [Related]
2. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
Sminia P; Schneider CJ; Fowler JF
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):844-9. PubMed ID: 11849810
[TBL] [Abstract][Full Text] [Related]
3. Equivalence of hyperfractionated and continuous brachytherapy in a rat tumor model and remarkable effectiveness when preceded by external irradiation.
Veninga T; Visser AG; van den Berg AP; van Hooije CM; van Geel CA; Levendag PC
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1351-60. PubMed ID: 11286843
[TBL] [Abstract][Full Text] [Related]
4. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
5. [In vitro studies of PDR brachytherapy].
Fritz P; Frank C; Weber KJ
Strahlenther Onkol; 1998 Jul; 174(7):365-74. PubMed ID: 9689958
[TBL] [Abstract][Full Text] [Related]
6. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
King CR
Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170
[TBL] [Abstract][Full Text] [Related]
7. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells.
Orton CG
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):183-9. PubMed ID: 11163513
[TBL] [Abstract][Full Text] [Related]
8. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments.
Visser AG; van den Aardweg GJ; Levendag PC
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):497-505. PubMed ID: 8567354
[TBL] [Abstract][Full Text] [Related]
9. [The dosage-performance effects on Ca-Ski and HPK cells in relation to the dose and fractionation].
Schulz-Wendtland R; Krämer S; Keilholz L; Pflüger S; Lang N
Strahlenther Onkol; 1996 Aug; 172(8):439-45. PubMed ID: 8765347
[TBL] [Abstract][Full Text] [Related]
10. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate.
Levendag PC; Schmitz PI; Jansen PP; Senan S; Eijkenboom WM; Sipkema D; Meeuwis CA; Kolkman-Deurloo IK; Visser AG
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):497-506. PubMed ID: 9231672
[TBL] [Abstract][Full Text] [Related]
11. Influence of dose-rate, post-irradiation incubation time and growth factors on interphase cell death by apoptosis and clonogenic survival of human peripheral lymphocytes.
Meijer AE; Saeidi AB; Zelenskaya A; Czene S; Granath F; Harms-Ringdahl M
Int J Radiat Biol; 1999 Oct; 75(10):1265-73. PubMed ID: 10549603
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
Tanaka E; Oh RJ; Yamada Y; Shiomi H; Nakamura S; Shimamoto S; Teshima T; Inoue T; Inoue T
Brachytherapy; 2003; 2(2):85-90. PubMed ID: 15062145
[TBL] [Abstract][Full Text] [Related]
13. The irradiation tolerance dose of the proximal vagina.
Au SP; Grigsby PW
Radiother Oncol; 2003 Apr; 67(1):77-85. PubMed ID: 12758243
[TBL] [Abstract][Full Text] [Related]
14. Radiobiological equivalent of low/high dose rate brachytherapy and evaluation of tumor and normal responses to the dose.
Manimaran S
Radiat Med; 2007 Jun; 25(5):229-35. PubMed ID: 17581712
[TBL] [Abstract][Full Text] [Related]
15. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
Kim WC; Kim GE; Suh CO; Loh JJ
Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
[TBL] [Abstract][Full Text] [Related]
16. IUdR polymers for combined continuous low-dose rate and high-dose rate sensitization of experimental human malignant gliomas.
Yuan X; Dillehay LE; Williams JR; Shastri VR; Williams JA
Int J Cancer; 2001 Apr; 96(2):118-25. PubMed ID: 11291095
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
Pop LA; Millar WT; Visser AG; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
[TBL] [Abstract][Full Text] [Related]
18. Inverse dose-rate-effects on the expressions of extra-cellular matrix-related genes in low-dose-rate gamma-ray irradiated murine cells.
Sugihara T; Murano H; Tanaka K; Oghiso Y
J Radiat Res; 2008 May; 49(3):231-40. PubMed ID: 18285661
[TBL] [Abstract][Full Text] [Related]
19. Twice-per-day fractionated high versus continuous low dose rate intracavitary therapy in the radical treatment of cervical cancer: a nonrandomized comparison of treatment results.
Hsu WL; Wu CJ; Jen YM; Yen SH; Lin KT; Ger LP; Kim RY
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1425-31. PubMed ID: 7635783
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate intracavitary irradiation using linear source arrangement for stage II and III squamous cell carcinoma of the uterine cervix.
Kagei K; Shirato H; Nishioka T; Kitahara T; Suzuki K; Tomita M; Takamura A; Arimoto T; Matsuoka S; Mizoe JE; Sakuragi N; Fujimoto S; Miyasaka K
Radiother Oncol; 1998 May; 47(2):207-13. PubMed ID: 9683371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
